Fact CheckerSign in

NCT07760688Recruiting

Structured Periprocedural Nursing Interventions in Men Undergoing Transrectal Prostate Biopsy

Impact of Structured Periprocedural Nursing Interventions on Resilience and Anxiety in Men Undergoing Transrectal Prostate Biopsy: A Prospective Longitudinal Interventions Study With Histopathological Stratification

Source: ClinicalTrials.gov · Last updated 12 Aug 2026

Brief summary (registry, in English)

This prospective longitudinal interventional study aims to evaluate the effect of structured peri-procedural nursing interventions on resilience and anxiety in men undergoing transrectal prostate biopsy. Participants will receive a standardized nursing intervention before and after the biopsy procedure. Resilience, anxiety, pain, lower urinary tract symptoms, and perceived nursing support will be assessed at predefined time points. Histopathological findings (benign or malignant) will be used for subgroup analyses. The study is conducted at the University Clinical Hospital Mostar, Bosnia and Herzegovina.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
120 (estimated)
First submitted
7 Aug 2026
Start date
4 Aug 2026
Primary completion date
4 Jul 2027
Lead sponsor
University of Mostar
NCT number
NCT07760688

What you commit to

  • Study type: Interventional
  • Planned participants: 120
  • From 4 Aug 2026 to the primary completion date, 4 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous disgnosis of prostate cancer.

Other illness

  • Severe cognitive impairment or psychiatric disorder preventing questionnaire completion.

Other

  • Inabillity to provide informed consent.
  • Inabillity to complete follow-up assessments.
  • Withdrawal of informed consent at any time.

Who the study is looking for

  • Male participants aged 40 years or older.
  • Scheduled for transrectal ultrasound-guided prostate biopsy because of suspected prostate cancer.
  • Able to understand the study procedures and provide written informed consent.
  • Willing to complete all study assessments during the follow-up period.

Age in the registry: 40 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Clinical Hospital Mostar
Coordinator of this site? Confirm its status
MostarBosnia and HerzegovinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.